Story
The Full Story
In four years Daqo's story has rotated three times. From 2020 through 2022 management told a capacity-and-cost story: build faster, ship more, dominate a tight market. By late 2023 the story had quietly inverted into a survival story — production cuts, idle facility costs, capital preservation. As of Q1 2026, it has become a policy story: management is sitting on $2 billion in cash, refusing to sell below cost, and waiting for Beijing to enforce minimum pricing on the polysilicon industry. Credibility on the cyclical call has deteriorated badly, but credibility on the operational and balance-sheet calls remains intact. The deck below shows where the narrative bent and what to believe now.
2025 Net Income ($M)
The 2022 peak — $4.6B revenue, $1.8B net income — was a once-in-a-cycle window driven by polysilicon spot prices breaching $40/kg. Two years later the same business booked a $345M loss on $1B revenue. Management's narrative did not adapt at the same speed as the price.
1. The Narrative Arc
Five inflection points define the last seven years. Everything else is rhyme.
The 2021–2022 period generated the cash that now funds 2024–2026 survival. Without the STAR Market IPO and the windfall earnings of FY22, the current "wait for policy" strategy would not be available — peers without that balance sheet are being forced to sell at a loss right now. This is the most important continuity in the story: cash from the boom is funding patience in the bust.
2. What Management Emphasized — and Then Stopped Emphasizing
The same management team has walked away from three growth themes in three years. The heatmap below tracks how often each topic dominated prepared remarks.
Three things stand out:
- Long-term customer contracts were the single most-emphasized theme in 2021 — Longgen Zhang named the LONGi, Zhonghuan, Wuxi Shangji, JinkoSolar agreements on every call, with prepayment percentages quoted to two decimal places. By 2024 the theme is gone. The agreements were either renegotiated, broken, or made irrelevant by spot prices.
- Semiconductor-grade polysilicon appeared in 2021 as a strategic optionality story (1,500 MT pilot, RMB3.5 billion investment, "replace imports"). Trial production started in May 2024. Since then, not mentioned in any prepared remarks. It is alive in the 20-F risk factors only.
- Anti-involution policy went from zero to dominant in two quarters (Q1 2025 → Q3 2025). Management has now built the entire forward narrative around a regulatory outcome that is still being negotiated.
The disappearance of long-term contracts is the most consequential narrative pivot. It signals that the relationship with Tier-1 wafer customers has reverted to spot pricing in a buyers' market — exactly the structure Daqo spent 2019–2021 trying to escape.
3. Risk Evolution
The risk language tracks the cycle almost perfectly. Forced-labor exposure was the dominant fear of 2021–2022 and then drained out of the conversation; oversupply replaced it; now it is policy execution.
Three observations on the drift:
- The Xinjiang / forced-labor exposure peaked in 2021 when the Biden administration banned imports of Hoshine silicon (Daqo's primary metallurgical-grade silicon supplier) and Daqo was added to the U.S. Entity List for direct shipments to the U.S. The risk is structurally still there — substantially all production remains in Shihezi, Xinjiang — but the narrative weight has dropped because Daqo's customer base has become fully Chinese, neutralizing UFLPA exposure on a flow basis. The 20-F still describes "risks of dealing with sanctioned persons" in identical language across 2021–2025.
- Idle facility costs are a 2024-onward phenomenon. They didn't exist as a line item before; today they are explicitly broken out at $0.74/kg (Q4 2025). This is the cost of running Phase 5A and 5B at 50–55% utilization rather than 100% — a structural margin headwind that did not exist when capacity was built.
- Anti-involution policy is the new dominant risk. As of Q1 2026 the strategy is "wait for government enforcement of minimum pricing"; if enforcement does not materialize by mid-2026, CFO Ming Yang has stated they will "lower utilization and start to sell at close to market pricing." This is a binary risk — and Daqo controls neither variable.
4. How They Handled Bad News
Daqo has handled three material bad-news episodes since 2020. The pattern is: explain the cyclical context, point to a structural fix, and emphasize the balance sheet. The wording has remained remarkably consistent across CEOs.
The two framings to interrogate:
- The 2024 first loss. Management framed industry oversupply as cyclical and pointed to expected price recovery. Eighteen months later prices collapsed further in Q1 2026, not recovered. The cyclical framing was directionally wrong on timing. The lowest-cost-producer claim, however, has held — Q4 2025 cash cost of $4.46/kg is a company record low.
- The Q1 2026 sales collapse. Sales of 4,482 MT against 43,402 MT of production is an extraordinary mismatch — Daqo essentially sat out the quarter. Management's framing is that this is a strategic decision, not a demand failure. The $98.4M inventory impairment recognized in the same quarter is a tell that the strategy carries real cost. It only works if Beijing enforces the price law in mid-2026 as expected.
5. Guidance Track Record
Operational guidance — quarterly production volumes, ramp dates, cost trajectories, IPO timing — has been delivered with high reliability. Cyclical guidance — polysilicon prices, demand timing, supply discipline — has been broadly wrong since 2022.
Splitting hits and misses by category makes the pattern unmistakable:
Credibility Score (1–10)
Out of
Score: 6/10. Operational delivery is exceptional — every facility ramp, every quarterly volume target, every IPO milestone, every cost trajectory has been hit. Pricing and capital-allocation guidance has been unreliable. The 720,000 MT capacity roadmap was the single largest miss; the most recent miss (RMB 53-54/kg minimum price) is the most concerning because it suggests management still mis-reads the policy environment they have put at the center of the thesis.
6. What the Story Is Now
The current story has three clean pieces — and one dependency that swallows everything else.
What is de-risked. The balance sheet is the most credible asset. $2.0B in cash + short-term investments + fixed-term deposits, zero financial debt, and a Q4 2025 cash cost of $4.46/kg that is a company record low. Operationally, Daqo has done what it said it would do every quarter: ramped Phase 5A and 5B on schedule, brought 305,000 MT of capacity online, and reduced unit electricity consumption to 52–55 kWh/kg. The cost-leadership claim is not just rhetoric — it is what is keeping the company solvent while peers burn cash.
What is stretched. The forward thesis is now entirely a Beijing put. Management is betting that the State Administration for Market Regulation, MIIT, and NDRC will (a) finalize a new industry cost model in mid-2026, (b) enforce a minimum selling price above production cost, and (c) shepherd consolidation that takes 1.0+ million MT of nameplate capacity out of the market. The pricing-law minimum management has guided to (RMB 53-54/kg) was already broken in Q1 2026 — actual transactional prices were RMB 35-37/kg. If enforcement does not materialize, CFO Ming Yang has explicitly said the company will lower utilization and start selling at market — which means renewed cash burn against a 3 million MT industry overhang that he himself describes as a 2-3 year unwind.
What to discount. Pricing and policy forecasts. Management has been wrong on poly price direction in seven of the last eight quarters and wrong on the minimum legal price in the first quarter that price law was supposed to bind. The 2025 Q3 prediction of RMB 60-80/kg post-consolidation now looks directionally implausible at any near-term horizon.
What to believe. Cash cost trajectory, production volume guidance, and balance sheet preservation. Where management has direct operational control they execute. Where they depend on a counterparty — customers in 2023, peers in 2025, regulators in 2026 — they are estimating, not predicting.
The story management is selling is: "We have the cash to outlast the bust; the government will enforce the floor; we will be the consolidator." The story the data is telling is: "We have the cash to outlast the bust" — which is the most important piece, but is only one of three. The other two are conditional on actors who have so far moved slower and softer than management has communicated.
A cleaner reading of where the company sits today:
| What it has | What it doesn't | What it needs |
|---|---|---|
| $2.0B liquidity, no debt | Pricing power | Beijing enforcement of price law |
| Lowest cash cost in industry ($4.46/kg) | Volume — sold only 4.5k MT in Q1 2026 | Industry consolidation removing 1M+ MT |
| 305k MT N-type capacity, ramped | A working long-term contract book | A demand-side recovery |
| Operational execution credibility | Cyclical-call credibility | Patience that may exceed 2-3 years |
The investment debate reduces to a single question: how long can $2 billion fund disciplined idleness, and will Beijing move before the cash position is meaningfully eroded? Management's own framing of a 2–3 year industry rebalance is the honest answer to the first half. The second half is unknowable from the inside.